JPRN-jRCT1061220085
Recruiting
Phase 2
Efficacy and safety of low dose-steroid treatment after steroid pulse therapy for acute exacerbation of idiopathic interstitial pneumonia -a pilot study- (FIT-dose Study) - FIT-dose Study
Takeshi Masuda0 sites11 target enrollmentJanuary 22, 2023
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Takeshi Masuda
- Enrollment
- 11
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Over 18 years old
- •2\. Witten informed consent
- •3\. Patients with acute exacerbation of idiopathic interstitial pneumonia
- •4\. Patients who do not require intubation or non\- invasive ventilation
- •5\. No progression of interstitial pneumonia on the 3rd day of steroid pulse therapy (methylprednisolone 1 g for 3 days)
Exclusion Criteria
- •1\. Patients receiving immunosuppressants
- •2\. Patients with interstitial pneumonia other than idiopathic interstitial pneumonia (e.g. collagen vascular disease, pneumoconiosis, drug\-induced pneumonia, radiation pneumonitis, sarcoidosis, hypersensitivity pneumonia)
- •3\. Patients with serum creatinine over 1\.5 times the upper limit of normal
- •4\. Patients with serious complications
- •5\. Patients who lack the ability to consent
- •6\. Patients with hypersensitivity to prednisolone
- •7\. Patients receiving desmopressin acetate hydrate
- •8\. Pregnancy
- •9\. Patients judged by the principal investigator or co\-investigator to be inappropriate for this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Efficacy and safety of low-dose steroid treatment in asymptomatic patients with autoimmune pancreatitis.autoimmune pancreatitisJPRN-UMIN000022633Osaka University20
Active, not recruiting
Not Applicable
Rationale for therapy with low dose steroids combined with long-acting beta2-agonists in patients with allergic asthma: redirecting innate immune responses by long-term treatment with high doses of inhaled steroidsEUCTR2007-000097-23-NLGlaxoSmithKline
Recruiting
Not Applicable
Efficacy and safety of corticosteroid monotherapy versus combination therapy of corticosteroid and tacrolimus for patients with anti-aminoacyl-tRNA synthetase antibody-positive polymyositis/dermatomyositis-associated interstitial lung disease: a prospective randomized multicenter clinical trialanti-aminoacyl-tRNA synthetase antibody-positive polymyositis/dermatomyositis/clinically amyopathic dermatomyositis-associated interstitial lung diseaseJPRN-UMIN000032022Hamamatsu University School of Medicine66
Completed
Not Applicable
Groningen Hand and Wrist Injection Therapy Trial (HAWITT)Tenosynovitis, carpal tunnel syndromeNervous System DiseasesMononeuropathies of upper limbISRCTN53171398niversity Medical Centre Groningen (UMCG) (Netherlands)120
Not yet recruiting
Not Applicable
Comparison of the efficacy and safety of steroid-impregnated self-crosslinked hyaluronic acid (PureRegen®) and steroid-impregnated bioabsorbable polyurethane foam (Nasopore®) in adults undergoing functional endoscopic sinus surgery (FESS) for chronic rhinosinusitis (CRS): a randomised controlled trial.chronic rhinosinusitisSurgery - Other surgeryInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12621000381886Gosford Hospital60